Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular Mechanisms of Lithium Action: Switching the Light on Multiple Targets for Dementia Using Animal Models
Fiona Kerr, Ivana Bjedov, Oyinkan Sofola-Adesakin
Frontiers in Molecular Neuroscience (2018) Vol. 11
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Glycogen Synthase Kinase-3 Inhibitors: Preclinical and Clinical Focus on CNS-A Decade Onward
Sara Arciniegas Ruiz, Hagit Eldar-Finkelman
Frontiers in Molecular Neuroscience (2022) Vol. 14
Open Access | Times Cited: 81
Lithium carbonate revitalizes tumor-reactive CD8+ T cells by shunting lactic acid into mitochondria
Jingwei Ma, Liang Tang, Yaoyao Tan, et al.
Nature Immunology (2024) Vol. 25, Iss. 3, pp. 552-561
Open Access | Times Cited: 36
GSK3: A Kinase Balancing Promotion and Resolution of Inflammation
Leonie Hoffmeister, Mareike Diekmann, Korbinian Brand, et al.
Cells (2020) Vol. 9, Iss. 4, pp. 820-820
Open Access | Times Cited: 108
Huperzine A and Its Neuroprotective Molecular Signaling in Alzheimer’s Disease
María Jesús Friedli, Nibaldo C. Inestrosa
Molecules (2021) Vol. 26, Iss. 21, pp. 6531-6531
Open Access | Times Cited: 72
Lithium and disease modification: A systematic review and meta-analysis in Alzheimer's and Parkinson’s disease
Monique Patrício Singulani, Ana Flávia Fernandes Ferreira, Paulina Sepúlveda Figueroa, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102231-102231
Closed Access | Times Cited: 12
New Advances in the Pharmacology and Toxicology of Lithium: A Neurobiologically Oriented Overview
Analı́a Bortolozzi, Giovanna Fico, Michael Berk, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 3, pp. 323-357
Open Access | Times Cited: 8
Insulin signaling as a therapeutic mechanism of lithium in bipolar disorder
Iain H. Campbell, Harry Campbell, Daniel J. Smıth
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 28
Lithium as a Treatment for Alzheimer’s Disease: The Systems Pharmacology Perspective
Harald Hampel, Simone Lista, Dalila Mango, et al.
Journal of Alzheimer s Disease (2019) Vol. 69, Iss. 3, pp. 615-629
Open Access | Times Cited: 54
Agephagy – Adapting Autophagy for Health During Aging
Eleanor Rachel Stead, Jorge Iván Castillo-Quan, Victoria Eugenia Martinez-Miguel, et al.
Frontiers in Cell and Developmental Biology (2019) Vol. 7
Open Access | Times Cited: 54
Efficacy and Safety of Glycogen Synthase Kinase 3 Inhibitors for Alzheimer’s Disease: A Systematic Review and Meta-Analysis
Shinji Matsunaga, Hiroshige Fujishiro, Hajime Takechi
Journal of Alzheimer s Disease (2019) Vol. 69, Iss. 4, pp. 1031-1039
Closed Access | Times Cited: 45
Autism-associated SHANK3 mutations impair maturation of neuromuscular junctions and striated muscles
Anne-Kathrin Lutz, Stefanie Pfaender, Berra Incearap, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 547
Closed Access | Times Cited: 45
Beyond its Psychiatric Use: The Benefits of Low-dose Lithium Supplementation
Sophie I. Hamstra, Brian D. Roy, Peter M. Tiidus, et al.
Current Neuropharmacology (2022) Vol. 21, Iss. 4, pp. 891-910
Open Access | Times Cited: 26
Keap1-independent Nrf2 regulation: a novel therapeutic target for treating kidney disease
Jiahui Zhang, Mingzhuo Zhang, Marc Tatar, et al.
Redox Biology (2025) Vol. 82, pp. 103593-103593
Open Access
Cerebral Small Vessel Disease: Therapeutic Approaches Targeting Neuroinflammation, Oxidative Stress, and Endothelial Dysfunction
Habibe Yılmaz, Ulvi Bayraktutan
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 4, pp. 232-232
Open Access
Application of optogenetic Amyloid-β distinguishes between metabolic and physical damages in neurodegeneration
Chu Hsien Lim, Prameet Kaur, Emelyne Teo, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 38
Is There Justification to Treat Neurodegenerative Disorders by Repurposing Drugs? The Case of Alzheimer’s Disease, Lithium, and Autophagy
Odeya Damri, Nofar Shemesh, Galila Agam
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 189-189
Open Access | Times Cited: 36
Minireview: Lithium: a therapeutic option in Alzheimer’s disease and its prodromal stages?
Robert Haußmann, Felix Noppes, Moritz Brandt, et al.
Neuroscience Letters (2021) Vol. 760, pp. 136044-136044
Closed Access | Times Cited: 29
Natural compounds from herbs and nutraceuticals as glycogen synthase kinase‐3β inhibitors in Alzheimer's disease treatment
Zheng Zhao, Ye Yuan, Shuang Li, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 8
Open Access | Times Cited: 4
Prevention of Alzheimer's disease by treating mild cognitive impairment with combinations chosen from eight available drugs
Jeffrey Fessel
Alzheimer s & Dementia Translational Research & Clinical Interventions (2019) Vol. 5, Iss. 1, pp. 780-788
Open Access | Times Cited: 33
Cure of Alzheimer’s Dementia Requires Addressing All of the Affected Brain Cell Types
Jeffrey Fessel
Journal of Clinical Medicine (2023) Vol. 12, Iss. 5, pp. 2049-2049
Open Access | Times Cited: 10
Lithium and the Interplay Between Telomeres and Mitochondria in Bipolar Disorder
Martin Lundberg, Vincent Millischer, Lena Backlund, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 26
Lithium chloride reduced the level of oxidative stress in brains and serums of APP/PS1 double transgenic mice via the regulation of GSK3β/Nrf2/HO-1 pathway
Jie Xiang, Kun Cao, Yang‐Ting Dong, et al.
International Journal of Neuroscience (2019) Vol. 130, Iss. 6, pp. 564-573
Closed Access | Times Cited: 23
Mesocortical BDNF signaling mediates antidepressive-like effects of lithium
Di Liu, Qianqian Tang, Di Wang, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 9, pp. 1557-1566
Open Access | Times Cited: 21
Lithium affects the circadian clock in the choroid plexus – A new role for an old mechanism
Karolína Liška, Tereza Dočkal, Pavel Houdek, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114292-114292
Open Access | Times Cited: 7
Low‐level lithium in drinking water and subsequent risk of dementia: Cohort study
Ashleigh C. Duthie, Jean Hannah, G. David Batty, et al.
International Journal of Geriatric Psychiatry (2023) Vol. 38, Iss. 3
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top